GLP-1 Users Are Losing Fat in Their Feet and Doctors Say It's a Real Problem

The Side Effect Nobody Warned You About

Doctors are warning about "Ozempic feet" — the unglamorous label for feet that suddenly look bonier, feel more painful, or no longer fit the shoes that were perfectly fine a few months earlier. As millions of Americans continue using GLP-1 medications like Ozempic and Wegovy to shed pounds, podiatrists and orthopedic specialists are seeing a new and unexpected trend walk through their doors.

Doctors across the country have reported seeing patients whose significant weight loss has left their feet looking bonier, looser, or more deflated due to a reduction in fat tissue. Doctors say the trend appears to be less about the drugs themselves than what can happen when weight comes off quickly from a part of the body most people rarely think about. And the numbers of people affected are only growing as GLP-1 prescriptions continue to surge.

What's Actually Happening to the Feet

According to Dr. Claire Morrow, an orthopedic clinical specialist, "If weight loss is too rapid, the skin doesn't have time to adjust." Experts say the changes are often most noticeable on the tops of the feet, where fat loss can make veins and tendons appear more prominent. Think of it like a deflating balloon — the structure is still there, but the cushioning that once filled it out is gone.

Dr. Dana Figura, a podiatric foot and ankle surgery specialist, said some patients on GLP-1 medications have described feeling as if they are "walking on pebbles." Others have reported burning or aching in the ball of the foot, heel pain, and shoe-fit problems they did not have before. Beyond the physical discomfort, there's a structural concern too. Researchers found that approximately 25% to 40% of the weight loss during GLP-1 treatment may be attributable to lean mass — and that could prove troubling for patients because small muscles in the feet help support the arches and keep the body stable while walking.

More Than Just a Cosmetic Issue

Some patients have gone down a full shoe size, and some have gone from a wide foot to a regular or narrow foot, Dr. Figura noted. That might sound like a minor inconvenience, but doctors are clear that it's anything but. "These aren't vanity complaints. They're functional problems that can lead to blisters, calluses, ulcers and, in patients with diabetes, much more serious wounds."

That bony, sagging look has already become social media fodder for celebrities who have been public about using weight-loss medication. Sharon Osbourne, who has said she lost 42 pounds on Ozempic, was picked apart online after sharing a photo with her grandson that left her feet on full display. But beyond the celebrity spotlight, the real concern is for everyday patients — particularly those with diabetes — who may not recognize the warning signs until a wound becomes serious.

What Patients Can Do Right Now

Morrow said people who lose more than 15 to 20 percent of their body weight in under a year may be at higher risk for these kinds of changes. That threshold is important to keep in mind, especially as GLP-1 medications are known for producing rapid, dramatic results. To help prevent undesirable side effects, doctors recommend maintaining protein intake, doing resistance training, and talking to a physician if weight loss is occurring too quickly. Morrow said patients may also want to ask whether their dose should be adjusted so weight comes off more gradually.

Figura also recommends getting feet measured again, wearing the correct shoe size, and using extra cushioning, such as heel cups or inserts, if the fat pads feel thinner. As GLP-1 drugs reshape how the country approaches obesity and metabolic health, the lesson from "Ozempic feet" may be a broader one: rapid transformation of the body rarely comes without trade-offs, and the ones that show up in unexpected places deserve just as much medical attention as the ones everyone is already watching for.